The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms

The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms: single blinded study - The Effects of Continuous Use of Three Cosmetic Products on Skin with Mild Atopic Dermatitis Symptoms

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000061084

Enrollment

Registered

2026-03-27

Start date

2026-03-27

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

The test articles were used for 4 weeks on only one side of the face and one side of the arm (three articles on the face-soap, lotion, and serum-and only the serum on the arm) Leave the other side of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Subjects diagnosed with atopic dermatitis or with a history of the condition 2.Subjects with a POEM score of 5-9 for the face and arms 3.Subjects whose symptoms have remained relatively stable over the past month and who have not started any new treatments or changed their current treatment regimen

Exclusion criteria

Exclusion criteria: 1.Individuals with excessive exudate, or those with extensive severe inflammation, bleeding, or excoriations 2.Individuals who have regularly used topical steroids, topical immunomodulators, or tacrolimus ointment within the past 2 weeks; individuals who have used oral steroids or immunosuppressants within the past 4 weeks; or individuals who have used biologics within the past 6 months 3.Individuals with skin conditions other than contact dermatitis, psoriasis, or atopic dermatitis on the study sites 4.Individuals who have undergone cosmetic medical procedures on the study sites 5.Pregnant or breastfeeding women, or women planning to become pregnant 6.Individuals undergoing hormone replacement therapy 7.Individuals with severe liver or kidney disease 8.Individuals who have undergone phototherapy within the past month 9.Individuals with an allergy to any component of the test product 10.Individuals who have participated in a human clinical trial within the past month, or who plan to do so during the study period

Design outcomes

Primary

Measure	Time frame
POEM, VAS Both before the start and 4 weeks later	—

Secondary

Measure	Time frame
Subjective Assessment 4 weeks later	—

Countries

Japan

Contacts

Public ContactTakeshi Kaneko

Japan Clinical Trial Association N.A.

info@yakujihou.org0364574666

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026